BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther 2019;20:1057-67. [PMID: 30990132 DOI: 10.1080/15384047.2019.1598759] [Cited by in Crossref: 90] [Cited by in F6Publishing: 145] [Article Influence: 30.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Rui K, Peng N, Luo H, Zhu B, Zuo X, Lu L, Chen J, Tian J. The cGAS-STING pathway: Post-translational modifications and functional implications in diseases. Cytokine Growth Factor Rev 2022:S1359-6101(22)00075-2. [PMID: 36151014 DOI: 10.1016/j.cytogfr.2022.09.003] [Reference Citation Analysis]
2 Jang A, Rauterkus GP, Vaishampayan UN, Barata PC. Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer. Onco Targets Ther 2022;15:897-912. [PMID: 36051571 DOI: 10.2147/OTT.S285758] [Reference Citation Analysis]
3 Tabata M, Liu X, Khamhanglit C, Kotaki S, Miyahara Y. Detection of Epidermal Growth Factor Receptor Expression in Breast Cancer Cell Lines Using an Ion-Sensitive Field-Effect Transistor in Combination with Enzymatic Chemical Signal Amplification. J Am Chem Soc 2022. [PMID: 36054724 DOI: 10.1021/jacs.2c06122] [Reference Citation Analysis]
4 Boerlin A, Bellini E, Turko P, Cheng PF, Levesque MP, Dummer R, Ramelyte E. The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. Cancers 2022;14:4158. [DOI: 10.3390/cancers14174158] [Reference Citation Analysis]
5 Herzog H, Dogan S, Aktas B, Nel I. Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer. Cancers 2022;14:4101. [DOI: 10.3390/cancers14174101] [Reference Citation Analysis]
6 Sarvari P, Sarvari P, Ramírez-díaz I, Mahjoubi F, Rubio K. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. IJMS 2022;23:9521. [DOI: 10.3390/ijms23179521] [Reference Citation Analysis]
7 Cabús L, Lagarde J, Curado J, Lizano E, Pérez-Boza J. Current challenges and best practices for cell-free long RNA biomarker discovery. Biomark Res 2022;10:62. [PMID: 35978416 DOI: 10.1186/s40364-022-00409-w] [Reference Citation Analysis]
8 Szadkowska P, Roura AJ, Wojtas B, Wojnicki K, Licholai S, Waller T, Gubala T, Zukowski K, Karpeta M, Wilkus K, Kaspera W, Nawrocki S, Kaminska B. Improvements in Quality Control and Library Preparation for Targeted Sequencing Allowed Detection of Potentially Pathogenic Alterations in Circulating Cell-Free DNA Derived from Plasma of Brain Tumor Patients. Cancers (Basel) 2022;14:3902. [PMID: 36010895 DOI: 10.3390/cancers14163902] [Reference Citation Analysis]
9 Shields MD, Chen K, Dutcher G, Patel I, Pellini B. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer. Int J Mol Sci 2022;23:9006. [PMID: 36012272 DOI: 10.3390/ijms23169006] [Reference Citation Analysis]
10 Malapelle U, Pisapia P, Pepe F, Russo G, Buono M, Russo A, Gomez J, Khorshid O, Mack PC, Rolfo C, Troncone G. The evolving role of liquid biopsy in lung cancer. Lung Cancer 2022;172:53-64. [PMID: 35998482 DOI: 10.1016/j.lungcan.2022.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Paulson V, Konnick EQ, Lockwood CH. When Tissue Is the Issue. Clinics in Laboratory Medicine 2022. [DOI: 10.1016/j.cll.2022.05.005] [Reference Citation Analysis]
12 Sánchez-herrero E, Serna-blasco R, Robado de Lope L, González-rumayor V, Romero A, Provencio M. Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis. Front Oncol 2022;12:943253. [DOI: 10.3389/fonc.2022.943253] [Reference Citation Analysis]
13 Mizuno Y, Shibata S, Miyagaki T, Ito Y, Taira H, Omori I, Hisamoto T, Oka K, Matsuda KM, Boki H, Takahashi-Shishido N, Sugaya M, Sato S. Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma. J Dermatol 2022. [PMID: 35821652 DOI: 10.1111/1346-8138.16520] [Reference Citation Analysis]
14 Yan X, Liu C. Clinical application and prospect of MRD evaluation in lung cancer based on ctDNA level: A review. Tumori 2022;:3008916221101927. [PMID: 35815471 DOI: 10.1177/03008916221101927] [Reference Citation Analysis]
15 Chan HT, Chin YM, Low S. Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges. Cancers 2022;14:3275. [DOI: 10.3390/cancers14133275] [Reference Citation Analysis]
16 Che H, Jatsenko T, Lenaerts L, Dehaspe L, Vancoillie L, Brison N, Parijs I, Van Den Bogaert K, Fischerova D, Heremans R, Landolfo C, Testa AC, Vanderstichele A, Liekens L, Pomella V, Wozniak A, Dooms C, Wauters E, Hatse S, Punie K, Neven P, Wildiers H, Tejpar S, Lambrechts D, Coosemans A, Timmerman D, Vandenberghe P, Amant F, Vermeesch JR. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets. Clin Chem 2022:hvac095. [PMID: 35769009 DOI: 10.1093/clinchem/hvac095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tutanov O, Tamkovich S. The Influence of Proteins on Fate and Biological Role of Circulating DNA. IJMS 2022;23:7224. [DOI: 10.3390/ijms23137224] [Reference Citation Analysis]
18 Zhang Q, He X, Ling J, Xiang Q, Li M, Zhao H, Fu Q, Tang Y, He J, Fan W, Zhang Y, Pan H, Peng J, Zheng Z. Association Between Circulating Cell-Free DNA Level at Admission and the Risk of Heart Failure Incidence in Acute Myocardial Infarction Patients. DNA Cell Biol 2022. [PMID: 35763313 DOI: 10.1089/dna.2022.0238] [Reference Citation Analysis]
19 Bessi S, Pepe F, Russo G, Pisapia P, Ottaviantonio M, Biancalani F, Iaccarino A, Russo M, Biancalani M, Troncone G, Malapelle U. Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study. J Clin Pathol 2022:jclinpath-2022-208308. [PMID: 35701144 DOI: 10.1136/jclinpath-2022-208308] [Reference Citation Analysis]
20 Tabata M, Khamhanglit C, Kotaki S, Miyahara Y. Detection of cell membrane proteins using ion-sensitive field effect transistors combined with chemical signal amplification. Chem Commun (Camb) 2022. [PMID: 35686960 DOI: 10.1039/d2cc02159e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bell LR, Gabbett TJ, Davis GM, Wallen MP, O'Brien BJ. Stubborn Exercise Responders-Where to Next? Sports (Basel) 2022;10:95. [PMID: 35736835 DOI: 10.3390/sports10060095] [Reference Citation Analysis]
22 Liu S, Wang J. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy. Curr Issues Mol Biol 2022;44:2695-709. [PMID: 35735625 DOI: 10.3390/cimb44060184] [Reference Citation Analysis]
23 Boniface CT, Spellman PT. Blood, Toil, and Taxoteres: Biological Determinates of Treatment-Induce ctDNA Dynamics for Interpreting Tumor Response. Pathol Oncol Res 2022;28:1610103. [PMID: 35665409 DOI: 10.3389/pore.2022.1610103] [Reference Citation Analysis]
24 Ahmad E, Ali A, Nimisha, Kumar Sharma A, Apurva, Kumar A, Mehdi G, Sumayya Abdul Sattar R, Verma R, Mahajan B, Singh Saluja S. Molecular markers in cancer. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.029] [Reference Citation Analysis]
25 Raoof S, Lee RJ, Jajoo K, Mancias JD, Rebbeck TR, Skates SJ. Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies. Cancer Epidemiol Biomarkers Prev 2022;31:1139-45. [PMID: 35320352 DOI: 10.1158/1055-9965.EPI-21-1443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Bahado-singh RO, Radhakrishna U, Gordevičius J, Aydas B, Yilmaz A, Jafar F, Imam K, Maddens M, Challapalli K, Metpally RP, Berrettini WH, Crist RC, Graham SF, Vishweswaraiah S. Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer’s Disease. Cells 2022;11:1744. [DOI: 10.3390/cells11111744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Huang Z, Lacourse SM, Kay AW, Stern J, Escudero JN, Youngquist BM, Zheng W, Vambe D, Dlamini M, Mtetwa G, Cranmer LM, Njuguna I, Wamalwa DC, Maleche-obimbo E, Catanzaro DG, Lyon CJ, John-stewart G, Dinardo A, Mandalakas AM, Ning B, Hu TY. CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study. The Lancet Microbe 2022. [DOI: 10.1016/s2666-5247(22)00087-8] [Reference Citation Analysis]
28 Flory A, Kruglyak KM, Tynan JA, McLennan LM, Rafalko JM, Fiaux PC, Hernandez GE, Marass F, Nakashe P, Ruiz-Perez CA, Fath DM, Jennings T, Motalli-Pepio R, Wotrang K, McCleary-Wheeler AL, Lana S, Phillips B, Flesner BK, Leibman NF, LaDue T, Tripp CD, Coomber BL, Woods JP, Miller M, Aiken SW, Wolf-Ringwall A, Borgatti A, Kraska K, Thomson CB, Kosanovich Cahalane A, Murray RL, Kisseberth WC, Camps-Palau MA, Floch F, Beaudu-Lange C, Klajer-Peres A, Keravel O, Fribourg-Blanc LA, Mazetier PC, Marco A, McLeod MB, Portillo E, Clark TS, Judd S, Feinberg CK, Benitez M, Runyan C, Hackett L, Lafey S, Richardson D, Vineyard S, Tefend Campbell M, Dharajiya N, Jensen TJ, van den Boom D, Diaz LA Jr, Grosu DS, Polk A, Marsal K, Hicks SC, Lytle KM, Holtvoigt L, Chibuk J, Chorny I, Tsui DWY. Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study. PLoS One 2022;17:e0266623. [PMID: 35471999 DOI: 10.1371/journal.pone.0266623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Guemri J, Pierre-Jean M, Brohard S, Oussada N, Horgues C, Bonnet E, Mauger F, Deleuze JF. Methylated ccfDNA from plasma biomarkers of Alzheimer's disease using targeted bisulfite sequencing. Epigenomics 2022. [PMID: 35416052 DOI: 10.2217/epi-2021-0491] [Reference Citation Analysis]
30 Guo L, Shen J, Lei W, Yan P, Wang M, Zhou Q, Wang H, Wu J, Chen J, Wang R. Plasma Donor-Derived Cell-Free DNA Levels Are Associated With the Inflammatory Burden and Macrophage Extracellular Trap Activity in Renal Allografts. Front Immunol 2022;13:796326. [PMID: 35386710 DOI: 10.3389/fimmu.2022.796326] [Reference Citation Analysis]
31 Futai N, Fukazawa Y, Kashiwagi T, Tamaki S, Sakai R, Hogan CA, Murugesan K, Ramachandran A, Banaei N, Santiago JG. A modular and reconfigurable open-channel gated device for the electrokinetic extraction of cell-free DNA assays. Analytica Chimica Acta 2022;1200:339435. [DOI: 10.1016/j.aca.2022.339435] [Reference Citation Analysis]
32 Ghanam J, Chetty VK, Barthel L, Reinhardt D, Hoyer PF, Thakur BK. DNA in extracellular vesicles: from evolution to its current application in health and disease. Cell Biosci 2022;12:37. [PMID: 35346363 DOI: 10.1186/s13578-022-00771-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Solanky D, Ahmed AA, Fierer J, Golts E, Jones M, Mehta SR. Utility of Plasma Microbial Cell-Free DNA Decay Kinetics After Aortic Valve Replacement for Bartonella Endocarditis: Case Report. Front Trop Dis 2022;3:842100. [DOI: 10.3389/fitd.2022.842100] [Reference Citation Analysis]
34 Nikolic A, Krivokapic Z. Nucleic acid-based markers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Surg Oncol 2022;41:101743. [PMID: 35358913 DOI: 10.1016/j.suronc.2022.101743] [Reference Citation Analysis]
35 Ershova ES, Shmarina GV, Porokhovnik LN, Zakharova NV, Kostyuk GP, Umriukhin PE, Kutsev SI, Sergeeva VA, Veiko NN, Kostyuk SV. In Vitro Analysis of Biological Activity of Circulating Cell-Free DNA Isolated from Blood Plasma of Schizophrenic Patients and Healthy Controls. Genes 2022;13:551. [DOI: 10.3390/genes13030551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Mio C, Damante G. Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy. Biochim Biophys Acta Mol Basis Dis 2022;1868:166390. [PMID: 35296416 DOI: 10.1016/j.bbadis.2022.166390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Pastorek M, Dúbrava M, Celec P. On the Origin of Neutrophil Extracellular Traps in COVID-19. Front Immunol 2022;13:821007. [DOI: 10.3389/fimmu.2022.821007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Werner B, Warton K, Ford CE. Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology. Cancers 2022;14:1309. [DOI: 10.3390/cancers14051309] [Reference Citation Analysis]
39 Ozturk EA, Caner A. Liquid Biopsy for Promising Non-invasive Diagnostic Biomarkers in Parasitic Infections. Acta Parasitol 2022;67:1-17. [PMID: 34176040 DOI: 10.1007/s11686-021-00444-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wang C, Wang W, Xu Y, Zhao X, Li S, Qian Q, Mi X. Tetrahedral DNA Framework-Programmed Electrochemical Biosenors with Gold Nanoparticles for Ultrasensitive Cell-Free DNA Detection. Nanomaterials 2022;12:666. [DOI: 10.3390/nano12040666] [Reference Citation Analysis]
41 Kim B, Kim Y, Shin S, Lee ST, Cho JY, Lee KA. Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer. Cancer Cell Int 2022;22:82. [PMID: 35168603 DOI: 10.1186/s12935-022-02504-2] [Reference Citation Analysis]
42 Peralta P, Hall MP, Singh Bhan S, Brown K, Parton MA, Yeshwant K, Finucane S, Keeling P, Ofman JJ. Industry engagement: Accelerating discovery, application, and adoption through industry partnerships. Cancer 2022;128 Suppl 4:918-26. [PMID: 35133660 DOI: 10.1002/cncr.34041] [Reference Citation Analysis]
43 Pękacz M, Basałaj K, Kalinowska A, Klockiewicz M, Stopka D, Bąska P, Długosz E, Karabowicz J, Młocicki D, Wiśniewski M, Zawistowska-Deniziak A. Selection of new diagnostic markers for Dirofilaria repens infections with the use of phage display technology. Sci Rep 2022;12:2288. [PMID: 35145147 DOI: 10.1038/s41598-022-06116-8] [Reference Citation Analysis]
44 Laggner M, Lingitz MT, Copic D, Direder M, Klas K, Bormann D, Gugerell A, Moser B, Radtke C, Hacker S, Mildner M, Ankersmit HJ, Haider T. Severity of thermal burn injury is associated with systemic neutrophil activation. Sci Rep 2022;12:1654. [PMID: 35102298 DOI: 10.1038/s41598-022-05768-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
45 Reddy T, Esmail A, Chang JC, Ghobrial RM, Abdelrahim M. Utility of Cell-Free DNA Detection in Transplant Oncology. Cancers (Basel) 2022;14:743. [PMID: 35159010 DOI: 10.3390/cancers14030743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
46 Zhang L, Coffin J, Formenti K, Chu Q, Izevbaye I. Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors. BMJ Open Respir Res 2022;9:e001154. [PMID: 35091437 DOI: 10.1136/bmjresp-2021-001154] [Reference Citation Analysis]
47 Herath S, Sadeghi Rad H, Radfar P, Ladwa R, Warkiani M, O’byrne K, Kulasinghe A. The Role of Circulating Biomarkers in Lung Cancer. Front Oncol 2022;11:801269. [DOI: 10.3389/fonc.2021.801269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Shtumpf M, Piroeva KV, Agrawal SP, Jacob DR, Teif VB. NucPosDB: a database of nucleosome positioning in vivo and nucleosomics of cell-free DNA. Chromosoma. [DOI: 10.1007/s00412-021-00766-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
49 Cushen SC, Ricci CA, Bradshaw JL, Silzer T, Blessing A, Sun J, Zhou Z, Scroggins SM, Santillan MK, Santillan DA, Phillips NR, Goulopoulou S. Reduced Maternal Circulating Cell-Free Mitochondrial DNA Is Associated With the Development of Preeclampsia. J Am Heart Assoc 2022;11:e021726. [PMID: 35014857 DOI: 10.1161/JAHA.121.021726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cisneros-villanueva M, Hidalgo-pérez L, Rios-romero M, Cedro-tanda A, Ruiz-villavicencio CA, Page K, Hastings R, Fernandez-garcia D, Allsopp R, Fonseca-montaño MA, Jimenez-morales S, Padilla-palma V, Shaw JA, Hidalgo-miranda A. Cell-free DNA analysis in current cancer clinical trials: a review. Br J Cancer. [DOI: 10.1038/s41416-021-01696-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
51 Pacia CP, Yuan J, Yue Y, Xu L, Nazeri A, Desai R, Gach HM, Wang X, Talcott MR, Chaudhuri AA, Dunn GP, Leuthardt EC, Chen H. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA. Theranostics 2022;12:362-78. [PMID: 34987650 DOI: 10.7150/thno.65597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
52 Moodley YP. Circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis: a new association. Thorax 2021:thoraxjnl-2021-218192. [PMID: 34880138 DOI: 10.1136/thoraxjnl-2021-218192] [Reference Citation Analysis]
53 Kinny-Köster B, Habib JR, Wolfgang CL, He J, Javed AA. Favorable tumor biology in locally advanced pancreatic cancer-beyond CA19-9. J Gastrointest Oncol 2021;12:2484-94. [PMID: 34790409 DOI: 10.21037/jgo-20-426] [Reference Citation Analysis]
54 Slagter AE, Vollebergh MA, Caspers IA, van Sandick JW, Sikorska K, Lind P, Nordsmark M, Putter H, Braak JPBM, Meershoek-Klein Kranenbarg E, van de Velde CJH, Jansen EPM, Cats A, van Laarhoven HWM, van Grieken NCT, Verheij M. Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial. Gastric Cancer 2021. [PMID: 34714423 DOI: 10.1007/s10120-021-01258-6] [Reference Citation Analysis]
55 Singhal A, Kumar S. Neutrophil and remnant clearance in immunity and inflammation. Immunology 2021. [PMID: 34704249 DOI: 10.1111/imm.13423] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
56 Purcell E, Owen S, Prantzalos E, Radomski A, Carman N, Lo TW, Zeinali M, Subramanian C, Ramnath N, Nagrath S. Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer. Front Cell Dev Biol 2021;9:724389. [PMID: 34692681 DOI: 10.3389/fcell.2021.724389] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
57 Kerachian MA, Azghandi M, Mozaffari-Jovin S, Thierry AR. Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA. Clin Epigenetics 2021;13:193. [PMID: 34663458 DOI: 10.1186/s13148-021-01182-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
58 Zangwill SD, Deshpande SR, Simpson PM, Liang HL, Zhang L, Dasgupta M, Richmond ME, Kindel SJ, Bichell DP, Mahle WT, Wigger MA, Schroder JN, Knecht KR, Pahl E, Gaglianello NA, North PE, Tomita-Mitchell A, Mitchell ME. Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. Clin Transplant 2021;:e14509. [PMID: 34649304 DOI: 10.1111/ctr.14509] [Reference Citation Analysis]
59 Thakur BL, Ray A, Redon CE, Aladjem MI. Preventing excess replication origin activation to ensure genome stability. Trends Genet 2021:S0168-9525(21)00269-9. [PMID: 34625299 DOI: 10.1016/j.tig.2021.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Lamminaho M, Kujala J, Peltonen H, Tengström M, Kosma VM, Mannermaa A. High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival. Cancers (Basel) 2021;13:4679. [PMID: 34572906 DOI: 10.3390/cancers13184679] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Stawski R, Stec-Martyna E, Chmielecki A, Nowak D, Perdas E. Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical Trials. Biology (Basel) 2021;10:906. [PMID: 34571783 DOI: 10.3390/biology10090906] [Reference Citation Analysis]
62 Udomruk S, Orrapin S, Pruksakorn D, Chaiyawat P. Size distribution of cell-free DNA in oncology. Crit Rev Oncol Hematol 2021;166:103455. [PMID: 34464717 DOI: 10.1016/j.critrevonc.2021.103455] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
63 Bredno J, Lipson J, Venn O, Aravanis AM, Jamshidi A. Clinical correlates of circulating cell-free DNA tumor fraction. PLoS One 2021;16:e0256436. [PMID: 34432811 DOI: 10.1371/journal.pone.0256436] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
64 de Miranda FS, Barauna VG, Dos Santos L, Costa G, Vassallo PF, Campos LCG. Properties and Application of Cell-Free DNA as a Clinical Biomarker. Int J Mol Sci 2021;22:9110. [PMID: 34502023 DOI: 10.3390/ijms22179110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
65 Hashimoto T, Yoshida K, Hashiramoto A, Matsui K. Cell-Free DNA in Rheumatoid Arthritis. Int J Mol Sci 2021;22:8941. [PMID: 34445645 DOI: 10.3390/ijms22168941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Balendran-Braun S, Kieler M, Liebmann-Reindl S, Unseld M, Bianconi D, W Prager G, Streubel B. Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing. Cancer Manag Res 2021;13:6249-61. [PMID: 34393517 DOI: 10.2147/CMAR.S308029] [Reference Citation Analysis]
67 Jordan PR, O'Leary DP, Fleming CA, Wang J, Redmond HP. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes. Surgeon 2021:S1479-666X(21)00125-6. [PMID: 34362650 DOI: 10.1016/j.surge.2021.06.006] [Reference Citation Analysis]
68 Hur JY, Lee KY. Characteristics and Clinical Application of Extracellular Vesicle-Derived DNA. Cancers (Basel) 2021;13:3827. [PMID: 34359729 DOI: 10.3390/cancers13153827] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
69 Barefoot ME, Loyfer N, Kiliti AJ, McDeed AP 4th, Kaplan T, Wellstein A. Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA. Front Genet 2021;12:671057. [PMID: 34386036 DOI: 10.3389/fgene.2021.671057] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
70 Kolarova TR, Gammill HS, Nelson JL, Lockwood CM, Shree R. At Preeclampsia Diagnosis, Total Cell-Free DNA Concentration is Elevated and Correlates With Disease Severity. J Am Heart Assoc 2021;10:e021477. [PMID: 34310191 DOI: 10.1161/JAHA.121.021477] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
71 Le Guin CHD, Bornfeld N, Bechrakis NE, Jabbarli L, Richly H, Lohmann DR, Zeschnigk M. Early detection of metastatic uveal melanoma by the analysis of tumor-specific mutations in cell-free plasma DNA. Cancer Med 2021. [PMID: 34291585 DOI: 10.1002/cam4.4153] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
72 Chidambaram S, Markar SR. Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2021:doab046. [PMID: 34286823 DOI: 10.1093/dote/doab046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Azab NA, Zahran FM, Amin AA, Rady NH. DNA integrity in diagnosis of premalignant lesions. Med Oral Patol Oral Cir Bucal 2021;26:e445-50. [PMID: 33340077 DOI: 10.4317/medoral.24287] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
74 Wilson-Robles H, Miller T, Jarvis J, Terrell J, Kelly TK, Bygott T, Bougoussa M. Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma. BMC Vet Res 2021;17:231. [PMID: 34187493 DOI: 10.1186/s12917-021-02934-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
75 Yee DW, Hetts SW, Greer JR. 3D-Printed Drug Capture Materials Based on Genomic DNA Coatings. ACS Appl Mater Interfaces 2021;13:41424-34. [PMID: 34124877 DOI: 10.1021/acsami.1c05209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Russo A, Incorvaia L, Del Re M, Malapelle U, Capoluongo E, Gristina V, Castiglia M, Danesi R, Fassan M, Giuffrè G, Gori S, Marchetti A, Normanno N, Pinto C, Rossi G, Santini D, Sartore-Bianchi A, Silvestris N, Tagliaferri P, Troncone G, Cinieri S, Beretta GD. The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies. ESMO Open 2021;6:100164. [PMID: 34091263 DOI: 10.1016/j.esmoop.2021.100164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
77 Lerone M, Ognibene M, Pezzolo A, Martucciello G, Zara F, Morini M, Mazzocco K. Molecular Genetics in Neuroblastoma Prognosis. Children (Basel) 2021;8:456. [PMID: 34072462 DOI: 10.3390/children8060456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Filipska M, Rosell R. Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment. Mol Oncol 2021;15:1667-82. [PMID: 33969622 DOI: 10.1002/1878-0261.12983] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
79 Adusei E, Ahenkorah J, Adu-Aryee NA, Adutwum-Ofosu KK, Tagoe EA, Koney NK, Nkansah E, Aryee NA, Blay RM, Hottor BA, Clegg-Lamptey JN, Arko-Boham B. Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients. Med Sci (Basel) 2021;9:37. [PMID: 34070520 DOI: 10.3390/medsci9020037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Kyeso Y, Bhalla A, Smith AP, Jia Y, Alakhdhair S, Ogir SC, Abuzeineh M, Brennan DC, Alasfar S. Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy. Transplant Direct 2021;7:e703. [PMID: 34056078 DOI: 10.1097/TXD.0000000000001149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Paracchini L, D'Incalci M, Marchini S. Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer-Current Use and Future Opportunities. Cancers (Basel) 2021;13:2386. [PMID: 34069200 DOI: 10.3390/cancers13102386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Shyr BU, Shyr BS, Chen SC, Chang SC, Shyr YM, Wang SE. Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer. Cancers (Basel) 2021;13:2313. [PMID: 34065893 DOI: 10.3390/cancers13102313] [Reference Citation Analysis]
83 Caggiano C, Celona B, Garton F, Mefford J, Black BL, Henderson R, Lomen-Hoerth C, Dahl A, Zaitlen N. Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE. Nat Commun 2021;12:2717. [PMID: 33976150 DOI: 10.1038/s41467-021-22901-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
84 Koval AP, Blagodatskikh KA, Kushlinskii NE, Shcherbo DS. The Detection of Cancer Epigenetic Traces in Cell-Free DNA. Front Oncol 2021;11:662094. [PMID: 33996585 DOI: 10.3389/fonc.2021.662094] [Reference Citation Analysis]
85 Yuwono NL, Henry CE, Ford CE, Warton K. Total and endothelial cell-derived cell-free DNA in blood plasma does not change during menstruation. PLoS One 2021;16:e0250561. [PMID: 33901234 DOI: 10.1371/journal.pone.0250561] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Mao X, Jakubovics NS, Bächle M, Buchalla W, Hiller KA, Maisch T, Hellwig E, Kirschneck C, Gessner A, Al-Ahmad A, Cieplik F. Colonization of Helicobacter pylori in the oral cavity - an endless controversy? Crit Rev Microbiol 2021;47:612-29. [PMID: 33899666 DOI: 10.1080/1040841X.2021.1907740] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
87 Fernández-Domínguez IJ, Manzo-Merino J, Taja-Chayeb L, Dueñas-González A, Pérez-Cárdenas E, Trejo-Becerril C. The role of extracellular DNA (exDNA) in cellular processes. Cancer Biol Ther 2021;22:267-78. [PMID: 33858306 DOI: 10.1080/15384047.2021.1890319] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
88 Jouida A, McCarthy C, Fabre A, Keane MP. Exosomes: a new perspective in EGFR-mutated lung cancer. Cancer Metastasis Rev 2021;40:589-601. [PMID: 33855679 DOI: 10.1007/s10555-021-09962-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Perillo A, Agbaje Olufemi MV, De Robbio J, Mancuso RM, Roscigno A, Tirozzi M, Scognamiglio IR. Liquid biopsy in NSCLC: a new challenge in radiation therapy. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00038] [Reference Citation Analysis]
90 Andargie TE, Tsuji N, Seifuddin F, Jang MK, Yuen PS, Kong H, Tunc I, Singh K, Charya A, Wilkins K, Nathan S, Cox A, Pirooznia M, Star RA, Agbor-Enoh S. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight 2021;6:147610. [PMID: 33651717 DOI: 10.1172/jci.insight.147610] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
91 Valenti F, Falcone I, Ungania S, Desiderio F, Giacomini P, Bazzichetto C, Conciatori F, Gallo E, Cognetti F, Ciliberto G, Morrone A, Guerrisi A. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response. Int J Mol Sci 2021;22:3837. [PMID: 33917181 DOI: 10.3390/ijms22083837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Marcatti M, Saada J, Okereke I, Wade CE, Bossmann SH, Motamedi M, Szczesny B. Quantification of Circulating Cell Free Mitochondrial DNA in Extracellular Vesicles with PicoGreen™ in Liquid Biopsies: Fast Assessment of Disease/Trauma Severity. Cells 2021;10:819. [PMID: 33917426 DOI: 10.3390/cells10040819] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
93 Chibuk J, Flory A, Kruglyak KM, Leibman N, Nahama A, Dharajiya N, van den Boom D, Jensen TJ, Friedman JS, Shen MR, Clemente-Vicario F, Chorny I, Tynan JA, Lytle KM, Holtvoigt LE, Murtaza M, Diaz LA Jr, Tsui DWY, Grosu DS. Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs. Front Vet Sci 2021;8:664718. [PMID: 33834049 DOI: 10.3389/fvets.2021.664718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
94 Yang L, Yang D, Yang Q, Cheng F, Huang Y. Extracellular DNA in blood products and its potential effects on transfusion. Biosci Rep 2020;40:BSR20192770. [PMID: 32150264 DOI: 10.1042/BSR20192770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Wang SC, Liao LM, Ansar M, Lin SY, Hsu WW, Su CM, Chung YM, Liu CC, Hung CS, Lin RK. Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response. Cancers (Basel) 2021;13:1375. [PMID: 33803633 DOI: 10.3390/cancers13061375] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
96 Toledano-Fonseca M, Cano MT, Inga E, Gómez-España A, Guil-Luna S, García-Ortiz MV, Mena-Osuna R, De la Haba-Rodriguez JR, Rodríguez-Ariza A, Aranda E. The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer. Cancers (Basel) 2021;13:1210. [PMID: 33802006 DOI: 10.3390/cancers13061210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
97 Santa P, Garreau A, Serpas L, Ferriere A, Blanco P, Soni C, Sisirak V. The Role of Nucleases and Nucleic Acid Editing Enzymes in the Regulation of Self-Nucleic Acid Sensing. Front Immunol 2021;12:629922. [PMID: 33717156 DOI: 10.3389/fimmu.2021.629922] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
98 Sin STK, Ji L, Deng J, Jiang P, Cheng SH, Heung MMS, Lau CSL, Leung TY, Chan KCA, Chiu RWK, Lo YMD. Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance. Clin Chem 2021;67:788-96. [PMID: 33615350 DOI: 10.1093/clinchem/hvaa326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
99 Mondelo-Macía P, Castro-Santos P, Castillo-García A, Muinelo-Romay L, Diaz-Peña R. Circulating Free DNA and Its Emerging Role in Autoimmune Diseases. J Pers Med 2021;11:151. [PMID: 33672659 DOI: 10.3390/jpm11020151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
100 Paul RS, Almokayad I, Collins A, Raj D, Jagadeesan M. Donor-derived Cell-free DNA: Advancing a Novel Assay to New Heights in Renal Transplantation. Transplant Direct 2021;7:e664. [PMID: 33564715 DOI: 10.1097/TXD.0000000000001098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Wallander K, Eisfeldt J, Lindblad M, Nilsson D, Billiau K, Foroughi H, Nordenskjöld M, Liedén A, Tham E. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients. PLoS One 2021;16:e0245488. [PMID: 33539436 DOI: 10.1371/journal.pone.0245488] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Murillo Carrasco A, Acosta O, Ponce J, Cotrina J, Aguilar A, Araujo J, Rebaza P, Pinto JA, Fujita R, Buleje J. PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer. J Clin Lab Anal 2021;35:e23720. [PMID: 33522650 DOI: 10.1002/jcla.23720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Papagoras C, Chrysanthopoulou A, Mitsios A, Ntinopoulou M, Tsironidou V, Batsali AK, Papadaki HA, Skendros P, Ritis K. IL-17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone-forming cells in ankylosing spondylitis. Eur J Immunol 2021;51:930-42. [PMID: 33340091 DOI: 10.1002/eji.202048878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
104 Young GP, Symonds EL, Nielsen HJ, Ferm L, Christensen IJ, Dekker E, van der Vlugt M, Mallant-Hent RC, Boulter N, Yu B, Chan M, Tevz G, LaPointe LC, Pedersen SK. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer. Clin Epigenetics 2021;13:14. [PMID: 33478584 DOI: 10.1186/s13148-020-00999-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Qasemi M, Mahdian R, Amidi F. Cell-free DNA discoveries in human reproductive medicine: providing a new tool for biomarker and genetic assays in ART. J Assist Reprod Genet 2021;38:277-88. [PMID: 33421023 DOI: 10.1007/s10815-020-02038-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
106 Mondelo-Macía P, García-González J, León-Mateos L, Castillo-García A, López-López R, Muinelo-Romay L, Díaz-Peña R. Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer. Biomedicines 2021;9:48. [PMID: 33430290 DOI: 10.3390/biomedicines9010048] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
107 Martuszewski A, Paluszkiewicz P, Król M, Banasik M, Kepinska M. Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review. J Clin Med 2021;10:E193. [PMID: 33430458 DOI: 10.3390/jcm10020193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
108 Del Real A, Perez-Campo FM, Perez-Nuñez MI, Sañudo C, Santurtun A, Garcia-Ibarbia C, Garcia-Unzueta MT, Fraga MF, Fernandez AF, Valero MC, Laguna E, Riancho JA. Methylation of the Sclerostin (SOST) Gene in Serum Free DNA: A New Bone Biomarker? Genet Test Mol Biomarkers 2021;25:42-7. [PMID: 33372860 DOI: 10.1089/gtmb.2020.0172] [Reference Citation Analysis]
109 Koçana CÇ, Toprak SF, Sözer S. Extracellular genetic materials and their application in clinical practice. Cancer Genet 2021;252-253:48-63. [PMID: 33387935 DOI: 10.1016/j.cancergen.2020.12.006] [Reference Citation Analysis]
110 Rungkamoltip P, Temisak S, Piboonprai K, Japrung D, Thangsunan P, Chanpanitkitchot S, Chaowawanit W, Chandeying N, Tangjitgamol S, Iempridee T. Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker. Exp Biol Med (Maywood) 2021;246:654-66. [PMID: 33307803 DOI: 10.1177/1535370220978899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Galardi F, Luca F, Romagnoli D, Biagioni C, Moretti E, Biganzoli L, Leo AD, Migliaccio I, Malorni L, Benelli M. Cell-Free DNA-Methylation-Based Methods and Applications in Oncology. Biomolecules 2020;10:E1677. [PMID: 33334040 DOI: 10.3390/biom10121677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
112 Thakral D, Gupta R, Sahoo RK, Verma P, Kumar I, Vashishtha S. Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA. Front Cell Dev Biol 2020;8:604391. [PMID: 33363162 DOI: 10.3389/fcell.2020.604391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
113 Gandini S, Zanna I, De Angelis SP, Cocorocchio E, Queirolo P, Lee JH, Carlino MS, Mazzarella L, Achutti Duso B, Palli D, Raimondi S, Caini S. Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis. Crit Rev Oncol Hematol 2021;157:103187. [PMID: 33276181 DOI: 10.1016/j.critrevonc.2020.103187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Speake C, Ylescupidez A, Neiman D, Shemer R, Glaser B, Tersey SA, Usmani-Brown S, Clark P, Wilhelm JJ, Bellin MD, Herold KC, Mirmira RG, Dor Y, Evans-Molina C. Circulating Unmethylated Insulin DNA As a Biomarker of Human Beta Cell Death: A Multi-laboratory Assay Comparison. J Clin Endocrinol Metab 2020;105:dgaa008. [PMID: 31913467 DOI: 10.1210/clinem/dgaa008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
115 Sastre-Garau X, Harlé A. Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor Markers. Front Oncol 2020;10:528957. [PMID: 33312940 DOI: 10.3389/fonc.2020.528957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Grabuschnig S, Bronkhorst AJ, Holdenrieder S, Rosales Rodriguez I, Schliep KP, Schwendenwein D, Ungerer V, Sensen CW. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms. Int J Mol Sci 2020;21:E8062. [PMID: 33137955 DOI: 10.3390/ijms21218062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
117 Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, Golubnitschaja O. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J 2020;:1-25. [PMID: 33144898 DOI: 10.1007/s13167-020-00226-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
118 Ou HL, Hoffmann R, González-López C, Doherty GJ, Korkola JE, Muñoz-Espín D. Cellular senescence in cancer: from mechanisms to detection. Mol Oncol 2020. [PMID: 32981205 DOI: 10.1002/1878-0261.12807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
119 Pessoa LS, Heringer M, Ferrer VP. ctDNA as a cancer biomarker: A broad overview. Crit Rev Oncol Hematol. 2020;155:103109. [PMID: 33049662 DOI: 10.1016/j.critrevonc.2020.103109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
120 Keller L, Belloum Y, Wikman H, Pantel K. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond. Br J Cancer 2021;124:345-58. [PMID: 32968207 DOI: 10.1038/s41416-020-01047-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 87] [Article Influence: 17.5] [Reference Citation Analysis]
121 Truszewska A, Wirkowska A, Gala K, Truszewski P, Krzemień-ojak Ł, Perkowska-ptasińska A, Mucha K, Pączek L, Foroncewicz B. Cell-free DNA profiling in patients with lupus nephritis. Lupus 2020;29:1759-72. [DOI: 10.1177/0961203320957717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
122 Santocki M, Kolaczkowska E. On Neutrophil Extracellular Trap (NET) Removal: What We Know Thus Far and Why So Little. Cells 2020;9:E2079. [PMID: 32932841 DOI: 10.3390/cells9092079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
123 Mego M, Kalavska K, Karaba M, Minarik G, Benca J, Sedlackova T, Gronesova P, Cholujova D, Pindak D, Mardiak J, Celec P. Plasma Nucleosomes in Primary Breast Cancer. Cancers (Basel) 2020;12:E2587. [PMID: 32927889 DOI: 10.3390/cancers12092587] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Sharma P, Anthwal D, Kumari P, Gupta RK, Lavania S, Sharma N, Sharma LK, Rath D, Soraganvi PK, Sharma A, Gadpayle AK, Taneja RS, Tyagi JS, Haldar S. Utility of circulating cell-free Mycobacterium tuberculosis DNA for the improved diagnosis of abdominal tuberculosis. PLoS One 2020;15:e0238119. [PMID: 32845896 DOI: 10.1371/journal.pone.0238119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
125 Elzanowska J, Semira C, Costa-Silva B. DNA in extracellular vesicles: biological and clinical aspects. Mol Oncol 2021;15:1701-14. [PMID: 32767659 DOI: 10.1002/1878-0261.12777] [Cited by in Crossref: 14] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
126 Chan HT, Chin YM, Nakamura Y, Low SK. Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications. Cancers (Basel) 2020;12:E2277. [PMID: 32823942 DOI: 10.3390/cancers12082277] [Cited by in Crossref: 18] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
127 Shandilya R, Bunkar N, Kumari R, Bhargava A, Chaudhury K, Goryacheva IY, Mishra PK. Immuno-cytometric detection of circulating cell free methylated DNA, post-translationally modified histones and micro RNAs using semi-conducting nanocrystals. Talanta 2021;222:121516. [PMID: 33167226 DOI: 10.1016/j.talanta.2020.121516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
128 Niwinska A, Bałabas A, Kulecka M, Kluska A, Piątkowska M, Paziewska A, Pyśniak K, Olszewski W, Mikula M, Ostrowski J. Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer. Diagnostics (Basel) 2020;10:E523. [PMID: 32731384 DOI: 10.3390/diagnostics10080523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
129 Malkin EZ, Bratman SV. Bioactive DNA from extracellular vesicles and particles. Cell Death Dis 2020;11:584. [PMID: 32719324 DOI: 10.1038/s41419-020-02803-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 56] [Article Influence: 14.0] [Reference Citation Analysis]
130 Pazdirek F, Minarik M, Benesova L, Halkova T, Belsanova B, Macek M, Stepanek L, Hoch J. Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response. Front Oncol 2020;10:1028. [PMID: 32793464 DOI: 10.3389/fonc.2020.01028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
131 Eslami-S Z, Cortés-Hernández LE, Alix-Panabières C. The Metastatic Cascade as the Basis for Liquid Biopsy Development. Front Oncol 2020;10:1055. [PMID: 32850309 DOI: 10.3389/fonc.2020.01055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
132 Castilhos LG, Oliveira JS, Adefegha SA, Manzoni AG, Passos DF, Assmann CE, Silveira LL, Trelles KB, Kronbauer M, Doleski PH, Bremm JM, Braun J, Abdalla FH, Gonçalves JF, Andrade CM, Cruz IBM, Burger ME, Leal DBR. Uncaria tomentosa improves cognition, memory and learning in middle-aged rats. Exp Gerontol 2020;138:111016. [PMID: 32628974 DOI: 10.1016/j.exger.2020.111016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
133 Vera IM, Kessler A, Ting LM, Harawa V, Keller T, Allen D, Njie M, Moss M, Soko M, Ahmadu A, Kadwala I, Ray S, Nyirenda TS, Mandala WL, Taylor TE, Rogerson SJ, Seydel KB, Kim K. Plasma cell-free DNA predicts pediatric cerebral malaria severity. JCI Insight 2020;5:136279. [PMID: 32554925 DOI: 10.1172/jci.insight.136279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
134 Chan HT, Nagayama S, Chin YM, Otaki M, Hayashi R, Kiyotani K, Fukunaga Y, Ueno M, Nakamura Y, Low SK. Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy. Mol Oncol 2020;14:1719-30. [PMID: 32449983 DOI: 10.1002/1878-0261.12727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
135 Foroni C, Zarovni N, Bianciardi L, Bernardi S, Triggiani L, Zocco D, Venturella M, Chiesi A, Valcamonico F, Berruti A. When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients. Biomedicines 2020;8:E131. [PMID: 32455948 DOI: 10.3390/biomedicines8050131] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
136 Veronese A. Genome DNA methylation, aneuploidy and immunity in cancer. Epigenomics 2020. [PMID: 32434377 DOI: 10.2217/epi-2020-0051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Arechederra M, Ávila MA, Berasain C. Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2020;1:20200009. [DOI: 10.1515/almed-2020-0009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
138 Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 2020;18:59. [PMID: 32264958 DOI: 10.1186/s12964-020-0530-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 277] [Article Influence: 47.5] [Reference Citation Analysis]
139 Ain Q, Schmeer C, Wengerodt D, Witte OW, Kretz A. Extrachromosomal Circular DNA: Current Knowledge and Implications for CNS Aging and Neurodegeneration. Int J Mol Sci 2020;21:E2477. [PMID: 32252492 DOI: 10.3390/ijms21072477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
140 Koulis C, Yap R, Engel R, Jardé T, Wilkins S, Solon G, Shapiro JD, Abud H, McMurrick P. Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer. Cancers (Basel) 2020;12:E812. [PMID: 32231042 DOI: 10.3390/cancers12040812] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
141 Campo DS, Khudyakov Y. Machine learning can accelerate discovery and application of cyber-molecular cancer diagnostics. J Med Artif Intell 2020;3. [PMID: 32478331 DOI: 10.21037/jmai.2020.01.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Wang J, Huang A, Wang YP, Yin Y, Fu PY, Zhang X, Zhou J. Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma. Ann Transl Med 2020;8:237. [PMID: 32309384 DOI: 10.21037/atm.2019.12.154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
143 Peddu V, Bradley BT, Casto AM, Shree R, Colbert BG, Xie H, Santo TK, Huang ML, Cheng EY, Konnick E, Salipante SJ, Jerome KR, Lockwood CM, Greninger AL. High-resolution profiling of human cytomegalovirus cell-free DNA in human plasma highlights its exceptionally fragmented nature. Sci Rep 2020;10:3734. [PMID: 32111931 DOI: 10.1038/s41598-020-60655-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Weiser DA, West-Szymanski DC, Fraint E, Weiner S, Rivas MA, Zhao CWT, He C, Applebaum MA. Progress toward liquid biopsies in pediatric solid tumors. Cancer Metastasis Rev 2019;38:553-71. [PMID: 31836951 DOI: 10.1007/s10555-019-09825-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
145 Karin-Kujundzic V, Sola IM, Predavec N, Potkonjak A, Somen E, Mioc P, Serman A, Vranic S, Serman L. Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers. Cells 2019;8:E1459. [PMID: 31752198 DOI: 10.3390/cells8111459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
146 Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, Tzanakakis G, Libra M, Tsatsakis A. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 2019;8:E1251. [PMID: 31615102 DOI: 10.3390/cells8101251] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 9.7] [Reference Citation Analysis]